Search

You searched for "grading"

3416 results found

Management of a giant pigment epithelium detachment with transition from half- to full-dose aflibercept

2 March 2026 | | EYE - Imaging, EYE - Vitreo-Retinal
This case report describes the management of a giant pigment epithelial detachment (PED) in neovascular age-related macular degeneration (nAMD) using half-dose aflibercept. An 80-year-old woman presented with a huge PED (maximum height 1338µm) and multiple risk factors for retinal pigment...

Behind the curtain: What trainees wish they knew before starting in ophthalmology

10 November 2025 | | EYE - General
As a foundation year doctor, I didn’t expect ophthalmology to feature much in acute medicine or surgery. Yet it kept appearing at the periphery – and when it did, it was often complex and unexpectedly urgent. A confused older patient...

UKISCRS Annual Congress 2026

19 November 2026 -20 November 2026
United Kingdom & Ireland Society of Cataract & Refractive Surgeons

Retina Subspecialty Day highlights from the RCOphth 2026 Annual Congress

5 August 2026 | | EYE - Vitreo-Retinal
Implementation of biosimilars in NHS retinal services A NHS England (NHSE) perspective Luke Nicholson (Moorfields Eye Hospital) explained that the NHSE perspective overall is structured on best value medicine for the patient and system, accounting for a finite budget and...
Seminars in Ophthalmology journal front cover image.

Diagnostic yield of routine metastatic work-up in conjunctival melanoma

3 April 2026 | | EYE - Orbit
Conjunctival melanoma (CM) is a rare but potentially aggressive malignancy of the ocular surface with high rates of local recurrence and metastasis. Eighty-one consecutive patients with invasive conjunctival melanoma treated by the senior author over the course of 23 years...

Are hospital cataract services managing more complex cases?

5 August 2026 | | EYE - Cataract
An audit of referral pathways and case mix in hospital cataract services. Cataract is the leading cause of irreversible blindness worldwide, causing severe visual impairment, particularly within ageing populations [1]. Gradual lens opacification impairs contrast sensitivity, visual acuity and overall...

Reflections as an international trainee

5 December 2025 | | EYE - Glaucoma, EYE - General
I had the privilege of undertaking two glaucoma fellowships in the UK – first at the St Paul’s Eye Unit in Liverpool (2022–23), followed by a second year at Moorfields Eye Hospital in London (2023–24). Many of my seniors had...

Part 1: The Arclight Project – Frugal tech for sight

3 April 2024 | | EYE - General
Click here for Part 2 on this topic, and here for Part 3 The Arclight Project is a mix of frugal design, manufacturing, distribution, teaching, research, and advocacy, all wrapped up in a social enterprise based at the University of...

RNIB says lack of accessible health information during COVID pandemic put blind and partially sighted people at greater risk

25 March 2026 | charity
The Royal National Institute of Blind People (RNIB) has responded to the report from the third module of the official UK Covid Inquiry which provides limited details of how a repeat of such a situation could be avoided in any...

Ask not what you can do for Glaucoma UK, but what Glaucoma UK can do for you

5 October 2026 | | EYE - Glaucoma
From patient information and professional training to research funding and participant recruitment, Glaucoma UK offers a wide range of support for everyone working in glaucoma care. You may already know Glaucoma UK as a source of information and support for...

The Association of British Dispensing Opticians (ABDO) achieves carbon neutrality

22 April 2022
The Association’s emissions have been reduced using a blend of offsets from a Gold Standard wind project and a Verra CCB4 forestry project to mix biodiversity protection and restoration with fuel switching to renewable energy.

Pituitary tumours: why are they so often missed?

1 August 2017 | | EYE - Neuro-ophthalmology
Part 2: Clinical varieties, anatomical considerations and case report (see also Part 1 and Part 3) For ophthalmologists there are four types of pituitary tumour to be considered, three of which are named according to the hormone secreted, along with...